Clinical Trial Update: Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence [Phase 4]

View source ↗

Summary

A Phase 4 patient-centered comparative effectiveness trial is examining home-based interventions to prevent recurrence of community-associated MRSA infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Staphylococcal Skin Infection

Snippet

Sponsor: Clinical Directors Network | Conditions: Methicillin-Resistant Staphylococcus Aureus, Recurrence | Phase 4 | Status: UNKNOWN